
David Kwiatkowski
Professor of Medicine, Harvard Medical School · Mass General Brigham
Credentials: · · · · ·
History
Research
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Cell · 2017 · 1,844 citations
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
Cell · 2012 · 1,525 citations
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
JAMA · 2014 · 1,437 citations

57 papers · 13 as a fellow

34 papers · 22 as a resident

28 papers
- EA
24 papers · 14 as a resident

20 papers
- ES
17 papers
- MS
16 papers
- BJ
15 papers
Grants
- 2006–2028
Molecular Pathogenesis of the Hamartoma Syndromes
National Cancer Institute · P01
Contact PI · $33.9M · Brigham and Women's Hospital
- 1997–2026
Dana-Farber/Harvard Cancer Center
National Cancer Institute · P30
Project lead · $483.6K · Dana-Farber Cancer Inst
- 2020–2025
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.8M · Brigham and Women's Hospital
- 2021–2023
National Cancer Institute · R21
PI · $476.3K · Dana-Farber Cancer Inst
Clinical trials
- 2016–2018
COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
Principal investigator · Completed · Phase 2
Brigham and Women's Hospital
- 2014–2019
Everolimus for Cancer With TSC1 or TSC2 Mutation
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute


